
FDA Draft Guidance on Third Party Review Program: Evaluation
The new article describes the matters related to periodic evaluations the authority intends to conduct to ensure compliance with the applicable regulatory regiments.
The new article describes the matters related to periodic evaluations the authority intends to conduct to ensure compliance with the applicable regulatory regiments.
The new article highlights the aspects related to the content and format of an application for initial recognition and re-recognition as a third-party 510k review organisation.
The new article describes in detail the applicable classification approach and highlights the key considerations associated thereto.
The article highlights the key points related to the specific aspects to be considered when using real-world data to support marketing applications related to medical devices.
The new article highlights the key points related to the studies to be carried out to demonstrate a positive supply effect.